Author(s)
Dr Sayantan Patra, Dr. Soumya Suvra Patra, Dr. Reetoja Das, Mrs. Sima Patra (Bhandari)
- Manuscript ID: 120688
- Volume 2, Issue 6, May 2026
- Pages: 687–696
Subject Area: Health Sciences
DOI: https://doi.org/10.5281/zenodo.20465816Abstract
Interventional Management of Lymphatic Disorders
Lymphatic abnormalities range from isolated malformations to complex system-wide abnormalities and lymphedema. The Central Conducting Lymphatics (CCL), comprised of the lumbar trunks, cisterna chyli, and thoracic duct, handle a daily flow of 8–12 L of interstitial fluid, with significant contributions from hepatic (50%) and mesenteric (40%) sources. Diagnosis is facilitated by functional imaging, such as Intranodal Dynamic Contrast-Enhanced MR Lymphangiography (DCEMRL) and the more rapid Intranodal CT Lymphangiography (INCTL). Management strategies are categorized by the SEOAS system (Symptoms, Etiology, Origin, Anatomy, Syndromic), utilizing sclerotherapy or embolization (e.g., Thoracic Duct Embolization) to treat leaks such as chylothorax, chylous ascites, and lymphoceles.